Showing results (211-220 of 418) with videos related to

Sort By:
Pageof 42
Journal of Tissue Engineering and Regenerative Medicine|July 28, 2010
Engineering of polymer-based grafts with cells derived from human nucleus pulposus tissue of the lumbar spineAldemar Andres Hegewald, Andreas Enz, Michaela Endres, et al.
Arthritis and Rheumatism|September 12, 2013
Indocyanine green-enhanced fluorescence optical imaging in patients with early and very early arthritis: a comparative study with magnetic resonance imagingStephanie G Werner, Hans-Eckhard Langer, Peter Schott, et al.
European Journal of Immunology|November 13, 2019
Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodiesQingyu Cheng, Andreas Pelz, Adriano Taddeo, et al.
Arthritis Research & Therapy|June 12, 2020
Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studiesMark C Genovese, Roy Fleischmann, Alan Kivitz, et al.
RMD Open|January 27, 2017
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndromeThomas Rose, Franziska Szelinski, Anna Lisney, et al.
Annals of the Rheumatic Diseases|September 8, 2012
The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapyTina M Backhaus, Sarah Ohrndorf, Herbert Kellner, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Arthritis Research & Therapy|July 21, 2009
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patientsKatrin Schmidt, Lorena Martinez-Gamboa, Susan Meier, et al.
Plos One|August 8, 2014
Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓKhetam Ghannam, Lorena Martinez-Gamboa, Lydia Spengler, et al.
Clinical and Experimental Rheumatology|March 3, 2022
Treatment of relapsing polychondritis: a systematic reviewArthur Petitdemange, Cédric Sztejkowski, Laura Damian, et al.
Pageof 42